Liaoning Chengda Biotechnology Co.,Ltd. (SHA:688739)
25.26
+0.34 (1.36%)
At close: Mar 6, 2026
SHA:688739 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | - | 4,496 | 4,548 | 5,797 | 2,829 |
Short-Term Investments | - | 30.12 | 60.19 | 291.13 | 270.72 |
Trading Asset Securities | - | 973.02 | 1,094 | - | 3,316 |
Cash & Short-Term Investments | 5,070 | 5,500 | 5,702 | 6,088 | 6,416 |
Cash Growth | -7.81% | -3.55% | -6.33% | -5.12% | 194.49% |
Accounts Receivable | - | 1,077 | 1,082 | 1,111 | 958.17 |
Other Receivables | - | 1.41 | 11.91 | 1.63 | 1.09 |
Receivables | - | 1,078 | 1,094 | 1,113 | 959.27 |
Inventory | - | 459.94 | 422.42 | 479.88 | 385.16 |
Prepaid Expenses | - | - | - | - | 2.02 |
Other Current Assets | - | 45.47 | 30.1 | 25.15 | 34.75 |
Total Current Assets | - | 7,083 | 7,249 | 7,706 | 7,798 |
Property, Plant & Equipment | - | 1,961 | 1,885 | 1,437 | 1,228 |
Long-Term Investments | - | 132.37 | 225.07 | 258.56 | 305.31 |
Other Intangible Assets | - | 181.45 | 178.87 | 187.21 | 123.35 |
Long-Term Deferred Tax Assets | - | 35.72 | 42.39 | 30.29 | 25.08 |
Long-Term Deferred Charges | - | 588.54 | 381.37 | 187.45 | 82.06 |
Other Long-Term Assets | - | 69.22 | 120.21 | 249.49 | 231.61 |
Total Assets | - | 10,052 | 10,081 | 10,056 | 9,793 |
Accounts Payable | - | 5.22 | 15.76 | 16.33 | 3.1 |
Accrued Expenses | - | 189.18 | 158.48 | 165.97 | 176.43 |
Current Portion of Leases | - | 5.14 | 4.86 | 4.53 | 4.49 |
Current Income Taxes Payable | - | - | 26.99 | 18.86 | 24.17 |
Current Unearned Revenue | - | 3.65 | 1.97 | 0.16 | 3.1 |
Other Current Liabilities | - | 190.12 | 148.73 | 67.12 | 77.72 |
Total Current Liabilities | - | 393.31 | 356.79 | 272.99 | 289.01 |
Long-Term Leases | - | 10 | 15.14 | 17.4 | 21.91 |
Long-Term Unearned Revenue | - | 85.6 | 100.79 | 111.1 | 120.74 |
Long-Term Deferred Tax Liabilities | - | 0.19 | 9.5 | 4.66 | 9.03 |
Other Long-Term Liabilities | - | 0.01 | 0.01 | 0.01 | 0.02 |
Total Liabilities | - | 489.12 | 482.23 | 406.16 | 440.72 |
Common Stock | - | 416.45 | 416.45 | 416.45 | 416.45 |
Additional Paid-In Capital | - | 5,034 | 5,034 | 5,034 | 5,034 |
Retained Earnings | - | 4,262 | 4,248 | 4,199 | 3,901 |
Treasury Stock | - | -149.99 | -99.99 | - | - |
Shareholders' Equity | 9,387 | 9,562 | 9,599 | 9,650 | 9,352 |
Total Liabilities & Equity | - | 10,052 | 10,081 | 10,056 | 9,793 |
Total Debt | 12.22 | 15.14 | 20.01 | 21.93 | 26.41 |
Net Cash (Debt) | 5,058 | 5,484 | 5,682 | 6,066 | 6,390 |
Net Cash Growth | -7.78% | -3.48% | -6.33% | -5.07% | 193.28% |
Net Cash Per Share | 12.13 | 13.28 | 13.66 | 14.53 | 16.75 |
Filing Date Shares Outstanding | 431.99 | 411.64 | 412.86 | 416.45 | 416.45 |
Total Common Shares Outstanding | 411.25 | 411.64 | 413.47 | 416.45 | 416.45 |
Working Capital | - | 6,690 | 6,892 | 7,433 | 7,509 |
Book Value Per Share | 22.83 | 23.23 | 23.22 | 23.17 | 22.46 |
Tangible Book Value | 9,203 | 9,381 | 9,420 | 9,462 | 9,229 |
Tangible Book Value Per Share | 22.38 | 22.79 | 22.78 | 22.72 | 22.16 |
Buildings | - | 992.14 | 912.41 | 713.81 | 663.04 |
Machinery | - | 1,435 | 1,274 | 880.16 | 867.47 |
Construction In Progress | - | 465.58 | 438.82 | 454.03 | 210.84 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.